WSJ: “Publicly traded drug companies are encouraged by their shareholders to make drugs that either are priced in the thousands of dollars per prescription or can be prescribed for years.”

WSJ: “Publicly traded drug companies are encouraged by their shareholders to make drugs that either are priced in the thousands of dollars per prescription or can be prescribed for years. What turns off drug companies is a product with low profit margins, infrequent use and a high likelihood of liability lawsuits.” (via Hugh Hewitt)